Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
glaxosmithkline
5
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
amgen
bristol-myers squibb
clinical trials
gene therapy
akcea therapeutics
biogen
cancer
immunotherapy
ipo
loxo oncology
medical devices
What
cancer
5
×
bio
roundup
immunotherapy
medical
abbvie’s
advanced
ahead
allogene
annual
appetite
arrival
ash
award
barcelona
biofourmis
black
bread
bucks
butter
buyout
cash
celebrate
chance
clinical
conference
corner
crispr
data
day
days
death
decades
december's
dems
diabetes
diamond’s
diversity
drug
drugs
Language
unset
Current search:
glaxosmithkline
×
cancer
×
photo
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More